Abstract
Ovarian cancer is the most lethal among the gynecologic malignancies with approximately 70% of patients presenting with advanced tumor stage. The prognosis of patients with ovarian cancer is directly related to the tumor stage and residual tumor burden after cytoreductive surgery. Exploratory laparotomy has been the cornerstone in the management of ovarian cancer, as it offers staging and tumor debulking. Understaging at initial laparotomy, however, is a problem in up to 30%, mainly due to insufficient technique and unexpected peritoneal spread outside the pelvis. Sites difficult to assess intraoperatively including the posterior aspect of the liver and the dome of the diaphragm can be well demonstrated with multiplanar imaging. CT and alternatively MRI have been accepted as adjunct imaging modalities for preoperative staging ovarian cancer. Of these, multidetector CT is the imaging modality of choice for staging ovarian cancer. In a multidisciplinary team approach patient management may be guided towards an individualized treatment plan. The contribution of imaging includes (1) surgery planning including referral practice, (2) selection of candidates for primary chemotherapy by demonstration of non (optimally) resectable disease, and (3) tissue sampling in peritoneal carcinomatosis.
Similar content being viewed by others
References
Ozols RF (2005) Treatment goals in ovarian cancer. Int J Gynecol Cancer 5(suppl 1):3–11
Spencer JA (2005) A multidisciplinary approach to ovarian cancer at diagnosis. BJR 78:S94–S10
Parkin DM, Bray F, Pisani F, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
Colombo N, Van Gorp T, Parma G et al (2006) Ovarian cancer. Crit Rev Oncol/Hematol 60:159–179
Pignata S, Vermorken JB (2004) Ovarian cancer in the elderly. Crit Rev Oncol/Hematol 49:77–86
Ozols RF, Schwartz PE, Eifel PJ (2001) Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. In: De Vita VT Jr, Hellman S, Rosenberg SA (eds) Cancer. Principles and practice of oncology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1597–1632
Clark TG, Stewart ME, Altmann DG et al (2001) A prognostic model for ovarian cancer. Br J Cancer 85:944–952
Holschneider CH, Berek JS (2000) Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19:3–10
Seidman JD, Russell P, Kurman RJ (2002) Surface epithelial tumors of the ovary. In: Kurman RJ (ed) Blaustein’s pathology of the female genital tract. Springer Verlag, Berlin Heidelberg New York, pp 791–904
Ries LAG, Eisner MP, Kosary CL et al (2002) SEER a cancer statistics review, 1973–1999 http://seer.cancer.gov/csr/1973-199/ Bethesda, MD: National cancer institute
Berchuck A, Iversen ES, Lancaster JM et al (2005) Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Res 11:3686–3696
Vaisbuch E, Dgani R, Ben-Arie A et al (2005) The role of laparoscopy in ovarian tumors of low malignant potential and early-stage ovarian cancer. Obstet Gynecol Surv 60:326–330
Ovarian cancer. American cancer society. http://www. cancer.org
Staging announcement: FIGO cancer committee (1986) Gynecol Oncol 25:383–385
Carnino F, Fuda GC, Ciccone G et al (1997) Significance of lymph node sampling in epithelial carcinoma of the ovary. Gynecol Oncol 65:467–472
Javitt MC, Fleischer AC, Andreotti RF et al (2005) Staging and Follow-up of ovarian cancer. American college of Radiology. http://www.acr.org recommendations
Low RN, Duggan B, Barone RM et al (2005) Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year. Radiology 235:918–926
Forstner R, Kinkel K (2006) Adnexal masses: characterization of benign ovarian lesions. In: Hamm B, Forstner R (eds) CT and MRI of the female pelvis. Springer Verlag, Berlin Heidelberg New York, pp 195–230
Pannu H, Bristow RE, Montz FJ et al (2003) Multidetector CT of peritoneal carcinomatosis from ovarian cancer. RadioGraphics 23:687–701
Woodward PJ, Hosseinzadeh K, Saenger JS (2004) Radiologic staging of ovarian carcinoma with pathologic correlation. From the archives of the AFIP. Radiographics 24:225–246
Forstner R, Hricak H, Occhipinti K et al (1995) Ovarian cancer: staging with CT and MRI. Radiology 197:619–626
Tempany CM, Zou KH, Silverman et al (2000) Staging of advanced ovarian cancer: comparison of imaging modalities-report from the Radiology Oncology Group. Radiology 215:761–767
Coakley FV (2002) Staging ovarian cancer: role of imaging. Radiol Clin N Am 40:609–636
Yoshida Y, Kurokawa T, Kawahara K et al (2003) Incremental benefits of FDG Positron Emissions Tomography over CT alone for the preopetative staging of ovarian cancer. AJR 182:227–233
Forstner R (2006) CT and MRI in ovarian carcinoma. In: Hamm B, Forstner R (eds) CT and MRI of the female pelvis. Springer Verlag, Berlin Heidelberg New York, pp 231–261
Kurtz AB, Tsimikas JV, Tempany CMC et al (1999) Diagnosis and staging og ovatian cancer:comparative values of Doppler and conventional US, Ct, and MR imaging correlated with surgery and histopathologgic analysis-report of the Radiology diagnostic oncology group. Radiology 212:19–27
Bristow RE, del Carmen GM, Pannu HK et al (2003) Clinically occult recurrent ovarial cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 90:519–528
Sironi S, Messa C, Mangili G et al (2004) Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings. Radiology 233:433–440
Ricke J, Sehouli J, Hach C et al (2003) Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer. Eur Radiol 13:943–949
Mitchell DG, Hill MC, Hill S et al (1986) Serous carcinoma of the ovary: CT identification of metastatic calcified implants. Radiology 158:649–652
Low RN, Barone RM, Lacey C et al (1997) Peritoneal tumor: MRI with dilute oral Barium and intravenous Gadolinium-containing contrast agents compared with unenhanced MRI and CT. Radiology 204:513–520
Brasanac D, Boricic I, Todorovic V et al (2005) Umbilical metastasis (Sister Josef’s nodule) as a first sign of disseminated ovarian carcinoma: comparative immhunohistochemical analysis and its metastases. Int J Gynecol Cancer 15:377–381
Low RN, Chen SC, Barone R et al (2003) Distinguishing benign from malignant bowel obstruction in patients with malignancy: findings at MRI. Radiology 228:157–165
Coakley FV, Choi PH, Gougoutas CA et al (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495–499
Fujii S, Matsusue E, Nakanishi J et al (2006) Clinical utility of diffusion -weighted MR imaging in the diagnosis of ovarian tumor and peritoneal dissemination. RSNA abstract book p 750
Chen SS, Lee L (1983) Incidence of para-aortic and pelvic lymph node metastases in epithelial carcinoma of the ovary. Gynecol Oncol 16:95–100
Benedetti-Panici P, Greggi S, Maneschi F et al (1993) Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol 51:150–154
Rockall AG, Sohaib SA, Harisinghani MK et al (2005) Diagnostic performance of nanoparticle-enhanced MRI in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 12:2813–2821
Bristow RE, Giuntoli RL, Pannu HK et al (2005) Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes. Gynecol Oncol 99:294–300
Aronberg DJ, Peterson RR, Glazer HS et al (1986) Superior diaphragmatic lymph nodes: CT assessment. J Comput Assist Tomogr 10:937–941
Holloway BJ, Gore ME, Hern RP et al (1997) The significance of paracardiac lymph node enlargement in ovarian cancer. Clin Radiol 52:692–69
Sirlin CB, Casola G, Brown AM et al (2001) US of blunt abdominal trauma: importance of free fluid in women of reproductive age. Radiology 219:229–235
Shen-Gunther J, Mannel RS (2002) Ascites as a predictor of ovarian malignancy. Gynecol Oncol 87:77–83
Jacobs I, Bast RC (1989) The CA-125 tumour-associated antigen: a review of the literature. Human Reprod 4:1–12
Togashi K (2003) Ovarian cancer: the role of US, CT and MRI. Europ Radiol 13(Suppl 4):L87–L104
Bohm-Velez M, Mendelson E, Bree R et al (2000) Ovarian cancer screening. American College of Radiology. ACR Appropriateness criteria. Radiology 215:861–871
Zurawski VR, Knapp RC, Einhorn N et al (1988) An initial analysis of preoperative Ca 125 levels in patients with early stage ovarian carcinoma. Gynecol Oncol 30:7–14
Kinkel K, Ying L, Mehdizade A et al (2005) Indeterminate ovarian mass at US: incremental value of second imaging test for characterization- Meta-analysis and Bayesian Analysis. Radiology 236:85–94
Marhom E, Cohen I (2007) Fertility preservation options for women with malignancies. Obstet Gynecol Surv 62:58–72
Quayyum A, Coakley FV, Westphalen AC et al (2005) Role of CT and MRI in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gyneco Oncol 96:301–306
Du Bois A, Rochon J, Lamparter C et al (2005) The quality assurance program of the AGO Organkommission OVAR QS- Ovar. Pattern of care and reality in Germany. Zentralblatt Gynäkol 127:9–17
Giede KC, Kieser K, Dodge J, Rosen B (2005) Who should operate on patients with ovarian cancer. An evidence based review. Gynecol Oncol 99:447–461
Fischer D, Cordes T, Schroer A et al (2006) Die radikale Primäroperation des fortgeschrittenen Ovarialkarzinoms. Gynäkologe 39:762–767
Aletti GD, Dowdi SC, Gostout BS et al (2006) Aggressive surgical effort and improved survival in advanced stage ovarian cancer. Obstet Gynecol 107:77–85
Ansquer Y, Leblanc E, Clough K et al (2001) Neoadjuvant chemotherapy for unresectable ovarian carcinoma. Cancer 91:2329–2334
Schwartz PE, Chambers JT, Makuch R (1994) Neoadjuvant chemotherapy for advanced ovarian cancer. Gynecol Oncol 53:33–37
Bristow RE, Tomacruz RS, Armstrong DK et al (2002) Survival effects of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta analysis. J Clin Oncol 20:1248–1259
Huober J, Meyer A, Wagner U, Wallwiener D (2002) The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer. Cancer Res Clin Oncol 128:153–160
Van der Burg ME (2001) Advanced ovarian cancer. Curr Treat Options Oncol 2:109–118
Nelson BE, Rosenfield AT, Schwartz PE (1993) Preoperative abdominopelvic CT prediction of optimal cytoreduction in epithelial ovarian cancer. J Clin Oncol 11:166–172
Bristow RE, Duska LR, Lambrou NC et al (2000) A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89:1532–1540
Spencer JA, Anderson K, Takeuchi E et al (2006) Radiological findings and image guided biopsy in women with peritoneal carcinomatosis and a history of breast cancer. ESUR abstract book p 22
Spencer JA, Swift SE, Wilkinson N et al (2001) Peritoneal carcinomatosis: image guided peritoneal core biopsy for tumor type and patient management 221:173–177
Hewitt MJ, Hall GD, Wilkinson N et al (2006) Image-guided biopsy in women with breast cancer presenting with peritoneal carcinomatosis. Int J Gynecol Cancer (2006) 16(Suppl 1):108–110
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Forstner, R. Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI. Eur Radiol 17, 3223–3235 (2007). https://doi.org/10.1007/s00330-007-0736-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-007-0736-5